Cargando…
Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle
Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistanc...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886697/ https://www.ncbi.nlm.nih.gov/pubmed/36083436 http://dx.doi.org/10.1007/s11357-022-00651-y |
_version_ | 1784880186593902592 |
---|---|
author | Brook, Matthew S. Wilkinson, Daniel J. Tarum, Janelle Mitchell, Kyle W. Lund, Jonathan L. Phillips, Bethan E. Szewczyk, Nathaniel J. Kadi, Fawzi Greenhaff, Paul L. Smith, Ken Atherton, Philip J. |
author_facet | Brook, Matthew S. Wilkinson, Daniel J. Tarum, Janelle Mitchell, Kyle W. Lund, Jonathan L. Phillips, Bethan E. Szewczyk, Nathaniel J. Kadi, Fawzi Greenhaff, Paul L. Smith, Ken Atherton, Philip J. |
author_sort | Brook, Matthew S. |
collection | PubMed |
description | Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistance exercise training (RET). Muscle biopsies were taken at baseline and after 3-/6-week training. We determined muscle size by fibre CSA (and type), SC number, myonuclei counts and DNA synthesis (via D(2)O ingestion). At baseline, there were no significant differences in fibre areas between Y and O. RET increased type I fibre area in Y from baseline at both 3 weeks and 6 weeks (baseline: 4509 ± 534 µm(2), 3 weeks; 5497 ± 510 µm(2) P < 0.05, 6 weeks; 5402 ± 352 µm(2) P < 0.05), whilst O increased from baseline at 6 weeks only (baseline 5120 ± 403 µm(2), 3 weeks; 5606 ± 620 µm(2), 6 weeks; 6017 ± 482 µm(2) P < 0.05). However, type II fibre area increased from baseline in Y at both 3 weeks and 6 weeks (baseline: 4949 ± 459 µm(2), 3 weeks; 6145 ± 484 µm(2) (P < 0.01), 6 weeks; 5992 ± 491 µm(2) (P < 0.01), whilst O showed no change (baseline 5210 ± 410 µm(2), 3 weeks; 5356 ± 535 µm(2) (P = 0.9), 6 weeks; 5857 ± 478 µm(2) (P = 0.1). At baseline, there were no differences in fibre myonuclei number between Y and O. RET increased type I fibre myonuclei number from baseline in both Y and O at 3 weeks and 6 weeks with RET (younger: baseline 2.47 ± 0.16, 3 weeks; 3.19 ± 0.16 (P < 0.001), 6 weeks; 3.70 ± 0.29 (P < 0.0001); older: baseline 2.29 ± 0.09, 3 weeks; 3.01 ± 0.09 (P < 0.001), 6 weeks; 3.65 ± 0.18 (P < 0.0001)). Similarly, type II fibre myonuclei number increased from baseline in both Y and O at 3 weeks and 6 weeks (younger: baseline 2.49 ± 0.14, 3 weeks; 3.31 ± 0.21 (P < 0.001), 6 weeks; 3.86 ± 0.29 (P < 0.0001); older: baseline 2.43 ± 0.12, 3 weeks; 3.37 ± 0.12 (P < 0.001), 6 weeks; 3.81 ± 0.15 (P < 0.0001)). DNA synthesis rates %.d(−1) exhibited a main effect of training but no age discrimination. Declines in myonuclei addition do not underlie impaired muscle growth capacity in older humans, supporting ribosomal and proteostasis impairments as we have previously reported. |
format | Online Article Text |
id | pubmed-9886697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-98866972023-02-01 Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle Brook, Matthew S. Wilkinson, Daniel J. Tarum, Janelle Mitchell, Kyle W. Lund, Jonathan L. Phillips, Bethan E. Szewczyk, Nathaniel J. Kadi, Fawzi Greenhaff, Paul L. Smith, Ken Atherton, Philip J. GeroScience Article Ageing limits growth capacity of skeletal muscle (e.g. in response to resistance exercise), but the role of satellite cell (SC) function in driving this phenomenon is poorly defined. Younger (Y) (~ 23 years) and older (O) men (~ 69 years) (normal-weight BMI) underwent 6 weeks of unilateral resistance exercise training (RET). Muscle biopsies were taken at baseline and after 3-/6-week training. We determined muscle size by fibre CSA (and type), SC number, myonuclei counts and DNA synthesis (via D(2)O ingestion). At baseline, there were no significant differences in fibre areas between Y and O. RET increased type I fibre area in Y from baseline at both 3 weeks and 6 weeks (baseline: 4509 ± 534 µm(2), 3 weeks; 5497 ± 510 µm(2) P < 0.05, 6 weeks; 5402 ± 352 µm(2) P < 0.05), whilst O increased from baseline at 6 weeks only (baseline 5120 ± 403 µm(2), 3 weeks; 5606 ± 620 µm(2), 6 weeks; 6017 ± 482 µm(2) P < 0.05). However, type II fibre area increased from baseline in Y at both 3 weeks and 6 weeks (baseline: 4949 ± 459 µm(2), 3 weeks; 6145 ± 484 µm(2) (P < 0.01), 6 weeks; 5992 ± 491 µm(2) (P < 0.01), whilst O showed no change (baseline 5210 ± 410 µm(2), 3 weeks; 5356 ± 535 µm(2) (P = 0.9), 6 weeks; 5857 ± 478 µm(2) (P = 0.1). At baseline, there were no differences in fibre myonuclei number between Y and O. RET increased type I fibre myonuclei number from baseline in both Y and O at 3 weeks and 6 weeks with RET (younger: baseline 2.47 ± 0.16, 3 weeks; 3.19 ± 0.16 (P < 0.001), 6 weeks; 3.70 ± 0.29 (P < 0.0001); older: baseline 2.29 ± 0.09, 3 weeks; 3.01 ± 0.09 (P < 0.001), 6 weeks; 3.65 ± 0.18 (P < 0.0001)). Similarly, type II fibre myonuclei number increased from baseline in both Y and O at 3 weeks and 6 weeks (younger: baseline 2.49 ± 0.14, 3 weeks; 3.31 ± 0.21 (P < 0.001), 6 weeks; 3.86 ± 0.29 (P < 0.0001); older: baseline 2.43 ± 0.12, 3 weeks; 3.37 ± 0.12 (P < 0.001), 6 weeks; 3.81 ± 0.15 (P < 0.0001)). DNA synthesis rates %.d(−1) exhibited a main effect of training but no age discrimination. Declines in myonuclei addition do not underlie impaired muscle growth capacity in older humans, supporting ribosomal and proteostasis impairments as we have previously reported. Springer International Publishing 2022-09-09 /pmc/articles/PMC9886697/ /pubmed/36083436 http://dx.doi.org/10.1007/s11357-022-00651-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Brook, Matthew S. Wilkinson, Daniel J. Tarum, Janelle Mitchell, Kyle W. Lund, Jonathan L. Phillips, Bethan E. Szewczyk, Nathaniel J. Kadi, Fawzi Greenhaff, Paul L. Smith, Ken Atherton, Philip J. Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title | Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title_full | Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title_fullStr | Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title_full_unstemmed | Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title_short | Neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
title_sort | neither myonuclear accretion nor a myonuclear domain size ceiling is a feature of the attenuated hypertrophic potential of aged human skeletal muscle |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886697/ https://www.ncbi.nlm.nih.gov/pubmed/36083436 http://dx.doi.org/10.1007/s11357-022-00651-y |
work_keys_str_mv | AT brookmatthews neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT wilkinsondanielj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT tarumjanelle neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT mitchellkylew neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT lundjonathanl neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT phillipsbethane neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT szewczyknathanielj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT kadifawzi neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT greenhaffpaull neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT smithken neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle AT athertonphilipj neithermyonuclearaccretionnoramyonucleardomainsizeceilingisafeatureoftheattenuatedhypertrophicpotentialofagedhumanskeletalmuscle |